Health Outcomes for people with Schizophrenia
The JEN Research Team has been working with the Health Economics and Outcomes Research Translational Science Team of Janssen Scientific Affairs, LLC.
The research has included studies of Medicare-Medicaid enrolled individuals with Schizophrenia and Schizoaffective Disorders
Early findings using the Medicare 5% sample were presented at the 27th Annual U.S. Psychiatric and Mental Health Congress in September 2014 in Orlando, Florida. Two posters were presented:
· Quality Indicators among Dually Eligible Medicare-Medicaid Patients with Schizophrenia see poster
· Health Care Utilization of Dually Eligible Patients with Schizoaffective Disorders see poster
Subsequent research has focused on the impact of long-acting antipsychotic treatments on hospitalization rates. A manuscript has been submitted for publication.